Who are GB001 recombinant peptide spray's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): insulin-like growth factor I.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/gb001-recombinant-peptide-spray.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

GB001 recombinant peptide spray — Competitive Intelligence Brief

GB001 recombinant peptide spray (GB001 recombinant peptide spray) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: recombinant peptide. Area: Respiratory.

phase 2 recombinant peptide Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

GB001 recombinant peptide spray (GB001 recombinant peptide spray) — Zhejiang Echon Biopharm Limited. GB001 recombinant peptide spray is a recombinant peptide that targets the underlying cause of a specific disease.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
GB001 recombinant peptide spray TARGET	GB001 recombinant peptide spray	Zhejiang Echon Biopharm Limited	phase 2	recombinant peptide
insulin-like growth factor I	insulin-like growth factor I	Children's Hospital of Philadelphia	marketed	Growth factor; recombinant peptide hormone	IGF-1 receptor (IGF1R)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (recombinant peptide class)

Zhejiang Echon Biopharm Limited · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). GB001 recombinant peptide spray — Competitive Intelligence Brief. https://druglandscape.com/ci/gb001-recombinant-peptide-spray. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab